Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 163

    1.

    Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone.

    Rahhal DN, Xu H, Huang WC, Wu S, Wen Y, Huang Y, Ildstad ST.

    Transplantation. 2009 Sep 27;88(6):773-781.PMID: 19920776 [PubMed - as supplied by publisher]Related articles

    2.

    Composite tissue allotransplantation: current challenges.

    Ravindra KV, Wu S, McKinney M, Xu H, Ildstad ST.

    Transplant Proc. 2009 Nov;41(9):3519-28.PMID: 19917338 [PubMed - in process]Related articles

    3.

    Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner.

    Ding C, Cai Y, Marroquin J, Ildstad ST, Yan J.

    J Immunol. 2009 Dec 1;183(11):7140-7149. Epub 2009 Nov 4.PMID: 19890051 [PubMed - as supplied by publisher]Related articles

    4.

    The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up.

    Sanganalmath SK, Stein AB, Guo Y, Tiwari S, Hunt G, Vincent RJ, Huang Y, Rezazadeh A, Ildstad ST, Dawn B, Bolli R.

    J Mol Cell Cardiol. 2009 Oct;47(4):528-35. Epub 2009 Jul 16.PMID: 19616005 [PubMed - indexed for MEDLINE]Related articles

    5.

    Stem cells as tools in regenerative therapy for retinal degeneration.

    Enzmann V, Yolcu E, Kaplan HJ, Ildstad ST.

    Arch Ophthalmol. 2009 Apr;127(4):563-71. Review.PMID: 19365041 [PubMed - indexed for MEDLINE]Related articles

    6.

    The history of human composite tissue allotransplantation.

    Tobin GR, Breidenbach WC 3rd, Ildstad ST, Marvin MM, Buell JF, Ravindra KV.

    Transplant Proc. 2009 Mar;41(2):466-71. Review.PMID: 19328905 [PubMed - indexed for MEDLINE]Related articles

    7.

    Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation.

    Wu S, Xu H, Ravindra K, Ildstad ST.

    Transplant Proc. 2009 Mar;41(2):463-5.PMID: 19328904 [PubMed - indexed for MEDLINE]Related articles

    9.

    Science of composite tissue allotransplantation.

    Swearingen B, Ravindra K, Xu H, Wu S, Breidenbach WC, Ildstad ST.

    Transplantation. 2008 Sep 15;86(5):627-35. Review.PMID: 18791440 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Composite tissue transplantation: a rapidly advancing field.

    Ravindra KV, Wu S, Bozulic L, Xu H, Breidenbach WC, Ildstad ST.

    Transplant Proc. 2008 Jun;40(5):1237-48. Review.PMID: 18589081 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Plasmacytoid precursor dendritic cells from NOD mice exhibit impaired function: are they a component of diabetes pathogenesis?

    Huang Y, Fugier-Vivier IJ, Miller T, Elliott MJ, Xu H, Bozulic LD, Chilton PM, Ildstad ST.

    Diabetes. 2008 Sep;57(9):2360-70. Epub 2008 Jun 20.PMID: 18567821 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.

    Huang Y, Ratajczak MZ, Reca R, Xu H, Tanner M, Rezzoug F, Hussain LR, Fugier-Vivier I, Bolli R, Ildstad ST.

    Transplantation. 2008 Apr 27;85(8):1175-84.PMID: 18431239 [PubMed - indexed for MEDLINE]Related articles

    13.

    TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function.

    Rezzoug F, Huang Y, Tanner MK, Wysoczynski M, Schanie CL, Chilton PM, Ratajczak MZ, Fugier-Vivier IJ, Ildstad ST.

    J Immunol. 2008 Jan 1;180(1):49-57.PMID: 18097003 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts.

    Adamson LA, Huang WC, Breidenbach WC, Rahhal D, Xu H, Huang Y, Pidwell DJ, Wei FC, Tobin G, Ildstad ST.

    Microsurgery. 2007;27(7):630-6.PMID: 17868137 [PubMed - indexed for MEDLINE]Related articles

    15.

    Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.

    Xu H, Yan J, Huang Y, Chilton PM, Ding C, Schanie CL, Wang L, Ildstad ST.

    Blood. 2008 Mar 15;111(6):3266-75. Epub 2007 Sep 7.PMID: 17827394 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Endogenous bone marrow derived cells express retinal pigment epithelium cell markers and migrate to focal areas of RPE damage.

    Li Y, Atmaca-Sonmez P, Schanie CL, Ildstad ST, Kaplan HJ, Enzmann V.

    Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4321-7.PMID: 17724223 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.

    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.

    Transplantation. 2007 Apr 15;83(7):954-63.PMID: 17460568 [PubMed - indexed for MEDLINE]Related articles

    18.

    Transplantation of the hand, face, and composite structures: evolution and current status.

    Tobin GR, Breidenbach WC 3rd, Pidwell DJ, Ildstad ST, Ravindra KV.

    Clin Plast Surg. 2007 Apr;34(2):271-8, ix-x. Review.PMID: 17418676 [PubMed - indexed for MEDLINE]Related articles

    19.

    Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD.

    Colson YL, Shinde Patil VR, Ildstad ST.

    Crit Rev Oncol Hematol. 2007 Jan;61(1):26-43. Epub 2006 Dec 5. Review.PMID: 17150368 [PubMed - indexed for MEDLINE]Related articles

    20.

    Systemically transferred hematopoietic stem cells home to the subretinal space and express RPE-65 in a mouse model of retinal pigment epithelium damage.

    Atmaca-Sonmez P, Li Y, Yamauchi Y, Schanie CL, Ildstad ST, Kaplan HJ, Enzmann V.

    Exp Eye Res. 2006 Nov;83(5):1295-302. Epub 2006 Sep 1.PMID: 16949576 [PubMed - indexed for MEDLINE]Related articles

    21.

    Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

    Xu H, Chilton PM, Tanner MK, Huang Y, Schanie CL, Dy-Liacco M, Yan J, Ildstad ST.

    Blood. 2006 Nov 15;108(10):3611-9. Epub 2006 Aug 3.PMID: 16888094 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Flt3-ligand-mobilized peripheral blood, but not Flt3-ligand-expanded bone marrow, facilitating cells promote establishment of chimerism and tolerance.

    Huang Y, Kucia M, Rezzoug F, Ratajczak J, Tanner MK, Ratajczak MZ, Schanie CL, Xu H, Fugier-Vivier I, Ildstad ST.

    Stem Cells. 2006 Apr;24(4):936-48.PMID: 16644924 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells.

    Li Y, Reca RG, Atmaca-Sonmez P, Ratajczak MZ, Ildstad ST, Kaplan HJ, Enzmann V.

    Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1646-52.PMID: 16565405 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.

    Dawn B, Guo Y, Rezazadeh A, Huang Y, Stein AB, Hunt G, Tiwari S, Varma J, Gu Y, Prabhu SD, Kajstura J, Anversa P, Ildstad ST, Bolli R.

    Circ Res. 2006 Apr 28;98(8):1098-105. Epub 2006 Mar 23.PMID: 16556872 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    FL-mobilized peripheral blood but not FL-expanded bone marrow FC promote establishment of chimerism and tolerance.

    Huang Y, Kucia M, Rezzoug F, Ratajczak J, Tanner MK, Ratajczak MZ, Schanie CL, Xu H, Fugier-Vivier I, Ildstad ST.

    Stem Cells. 2005 Dec 1. [Epub ahead of print]PMID: 16322638 [PubMed - as supplied by publisher]Related articlesFree article

    26.

    Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke.

    Kucia M, Zhang YP, Reca R, Wysoczynski M, Machalinski B, Majka M, Ildstad ST, Ratajczak J, Shields CB, Ratajczak MZ.

    Leukemia. 2006 Jan;20(1):18-28.PMID: 16270036 [PubMed - indexed for MEDLINE]Related articles

    27.

    NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: evidence for NK tolerance correlates with receptor editing.

    Huang Y, Rezzoug F, Xu H, Chilton PM, Schanie CL, Fugier-Vivier I, Ildstad ST.

    J Immunol. 2005 Sep 15;175(6):3753-61.PMID: 16148121 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment.

    Fugier-Vivier IJ, Rezzoug F, Huang Y, Graul-Layman AJ, Schanie CL, Xu H, Chilton PM, Ildstad ST.

    J Exp Med. 2005 Feb 7;201(3):373-83.PMID: 15699072 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.

    Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST.

    Transplantation. 2004 Dec 15;78(11):1582-9.PMID: 15591945 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction.

    Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ.

    Circ Res. 2004 Dec 10;95(12):1191-9. Epub 2004 Nov 18.PMID: 15550692 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.

    Xu H, Exner BG, Chilton PM, Schanie C, Ildstad ST.

    Stem Cells. 2004;22(6):1039-48.PMID: 15536194 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients.

    Chilton PM, Rezzoug F, Ratajczak MZ, Fugier-Vivier I, Ratajczak J, Kucia M, Huang Y, Tanner MK, Ildstad ST.

    Blood. 2005 Mar 1;105(5):2189-97. Epub 2004 Nov 2.PMID: 15522953 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes.

    Grimes HL, Schanie CL, Huang Y, Cramer D, Rezzoug F, Fugier-Vivier I, Ildstad ST.

    Exp Hematol. 2004 Oct;32(10):946-54.PMID: 15504550 [PubMed - indexed for MEDLINE]Related articles

    35.

    Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts.

    Colson YL, Xu H, Huang Y, Ildstad ST.

    J Immunol. 2004 Nov 1;173(9):5827-34.PMID: 15494536 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Flt3-ligand treatment prevents diabetes in NOD mice.

    Chilton PM, Rezzoug F, Fugier-Vivier I, Weeter LA, Xu H, Huang Y, Ray MB, Ildstad ST.

    Diabetes. 2004 Aug;53(8):1995-2002.PMID: 15277378 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    A delay in bone marrow transplantation after partial conditioning improves engraftment.

    Xu H, Exner BG, Chilton PM, Tanner MK, Mueller YM, Rezzoug F, Ildstad ST.

    Transplantation. 2004 Mar 27;77(6):819-26.PMID: 15077020 [PubMed - indexed for MEDLINE]Related articles

    38.

    Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment.

    Huang Y, Rezzoug F, Chilton PM, Grimes HL, Cramer DE, Ildstad ST.

    Blood. 2004 Aug 1;104(3):873-80. Epub 2004 Mar 30.PMID: 15054040 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Facilitating cells as a venue to establish mixed chimerism and tolerance.

    Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST.

    Pediatr Transplant. 2003 Oct;7(5):348-57. Review.PMID: 14738294 [PubMed - indexed for MEDLINE]Related articles

    40.

    Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.

    Xu H, Chilton PM, Huang Y, Schanie CL, Ildstad ST.

    J Immunol. 2004 Feb 1;172(3):1463-71.PMID: 14734723 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee.

    Gibbons RD, Duan N, Meltzer D, Pope A, Penhoet ED, Dubler NN, Francis C, Gill B, Guinan E, Henderson M, Ildstad ST, King PA, Martinez-Maldonado M, McLain GE, Murray J, Nelkin D, Spellman MW, Pitluck S; Institute of Medicine Committee.

    Biostatistics. 2003 Apr;4(2):207-22.PMID: 12925517 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.

    Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH.

    Transplantation. 2003 Apr 15;75(7):922-32.PMID: 12698075 [PubMed - indexed for MEDLINE]Related articles

    43.

    Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential.

    Mueller YM, Cramer DE, Huang Y, Exner BG, Ildstad ST.

    Transplantation. 2002 Apr 27;73(8):1177-85.PMID: 11981407 [PubMed - indexed for MEDLINE]Related articles

    44.

    Mixed allogeneic chimerism. Past, present, and prospects for the future.

    Brouha PC, Ildstad ST.

    Transplantation. 2001 Oct 27;72(8 Suppl):S36-42. Review. No abstract available. PMID: 11888155 [PubMed - indexed for MEDLINE]Related articles

    45.

    CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.

    Xu H, Exner BG, Cramer DE, Tanner MK, Mueller YM, Ildstad ST.

    J Immunol. 2002 Feb 15;168(4):1636-43.PMID: 11823491 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.

    Huang Y, Cramer DE, Ray MB, Chilton PM, Que X, Ildstad ST.

    Transplantation. 2001 Dec 27;72(12):1907-14.PMID: 11773887 [PubMed - indexed for MEDLINE]Related articles

    47.

    Impact of bone marrow transplantation on type I diabetes.

    Domenick MA, Ildstad ST.

    World J Surg. 2001 Apr;25(4):474-80. Epub 2001 Apr 11. Review.PMID: 11344401 [PubMed - indexed for MEDLINE]Related articles

    48.

    Bone marrow cell graft engineering: from bench to bedside.

    Chilton PM, Huang Y, Ildstad ST.

    Leuk Lymphoma. 2001 Mar;41(1-2):19-34. Review.PMID: 11342354 [PubMed - indexed for MEDLINE]Related articles

    49.

    Establishment of fully xenogeneic (mouse-->rat) bone marrow chimeras: evidence for normal development and clonal deletion of mouse T cells.

    Mohiuddin MM, Ildstad ST, DiSesa VJ.

    Transplantation. 2000 Mar 15;69(5):731-6.PMID: 10755518 [PubMed - indexed for MEDLINE]Related articles

    50.

    Mixed allogeneic chimerism and tolerance to composite tissue allografts.

    Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, Ildstad ST.

    Microsurgery. 2000;20(8):441-7. Review.PMID: 11150997 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...